Remove DEA Remove Medical Evaluation Remove Safety Remove State Laws
article thumbnail

Rescheduling Marijuana

Connor & Connor PLLC

Currently, marijuana is a Schedule I substance, meaning it is thought to have no medical value, a high probability of addiction, and a lack of any accepted safety or use in medically supervised treatment. On May 21, 2024, the DEA opened a 62-day public comment period, which concluded on July 22, 2024.

article thumbnail

Further Consideration of the STATES Act

Cannabis Law Report

The Attorney General forwards the request to the Health and Human Services Secretary and requests a scientific and medical evaluation and recommendation, as specified by 23 USC 811(b-c). The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. Emphasis added).

Banking 45